194 related articles for article (PubMed ID: 31893577)
1. Long intergenic non-coding RNA 511 correlates with improved prognosis, and hinders osteosarcoma progression both in vitro and in vivo.
Qiao S; Qi K; Liu C; Xu C; Ma J; Xu X; Li C; Wang Z
J Clin Lab Anal; 2020 May; 34(5):e23164. PubMed ID: 31893577
[TBL] [Abstract][Full Text] [Related]
2. Long intergenic non-protein coding RNA 511 promotes the progression of osteosarcoma cells through sponging microRNA 618 to upregulate the expression of maelstrom.
Guo W; Yu Q; Zhang M; Li F; Liu Y; Jiang W; Jiang H; Li H
Aging (Albany NY); 2019 Aug; 11(15):5351-5367. PubMed ID: 31386627
[TBL] [Abstract][Full Text] [Related]
3. Downregulated Long Non-Coding RNA MSC-AS1 Inhibits Osteosarcoma Progression and Increases Sensitivity to Cisplatin by Binding to MicroRNA-142.
Zhang L; Zhao G; Ji S; Yuan Q; Zhou H
Med Sci Monit; 2020 Mar; 26():e921594. PubMed ID: 32155139
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of Long Non-Coding RNA NNT-AS1 Correlates with Tumor Progression and Poor Prognosis in Osteosarcoma.
Ye H; Lin J; Yao X; Li Y; Lin X; Lu H
Cell Physiol Biochem; 2018; 45(5):1904-1914. PubMed ID: 29518771
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA XIST promotes osteosarcoma progression by targeting YAP via miR-195-5p.
Yang C; Wu K; Wang S; Wei G
J Cell Biochem; 2018 Jul; 119(7):5646-5656. PubMed ID: 29384226
[TBL] [Abstract][Full Text] [Related]
6. MiR-363 suppresses cell migration, invasion, and epithelial-mesenchymal transition of osteosarcoma by binding to NOB1.
Zhang Y; Wang F; Wang L; Zhang Q
World J Surg Oncol; 2020 May; 18(1):83. PubMed ID: 32357945
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA CTA sensitizes osteosarcoma cells to doxorubicin through inhibition of autophagy.
Wang Z; Liu Z; Wu S
Oncotarget; 2017 May; 8(19):31465-31477. PubMed ID: 28415557
[TBL] [Abstract][Full Text] [Related]
8. LncRNA BLACAT1 accelerates the proliferation and migration of osteosarcoma cells through regulating STAT3.
Dong Z; Wang Y
Pathol Res Pract; 2019 Mar; 215(3):571-579. PubMed ID: 30665678
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of long non-coding RNA DBH-AS1 inhibits osteosarcoma progression by PI3K-AKT signaling pathways and indicates good prognosis.
Liu ZB; Wang JA; Lv RQ
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1418-1427. PubMed ID: 30840262
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA LINC00511 involves in breast cancer recurrence and radioresistance by regulating STXBP4 expression via miR-185.
Liu L; Zhu Y; Liu AM; Feng Y; Chen Y
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7457-7468. PubMed ID: 31539133
[TBL] [Abstract][Full Text] [Related]
11. Mediator of RNA polymerase II transcription subunit 19 promotes osteosarcoma growth and metastasis and associates with prognosis.
Yu W; Zhang Z; Min D; Yang Q; Du X; Tang L; Lin F; Sun Y; Zhao H; Zheng S; He A; Li H; Yao Y; Shen Z
Eur J Cancer; 2014 Apr; 50(6):1125-36. PubMed ID: 24565852
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA small nucleolar RNA host gene 12 (SNHG12) promotes cell proliferation and migration by upregulating angiomotin gene expression in human osteosarcoma cells.
Ruan W; Wang P; Feng S; Xue Y; Li Y
Tumour Biol; 2016 Mar; 37(3):4065-73. PubMed ID: 26486328
[TBL] [Abstract][Full Text] [Related]
13. LOXL1-AS1 predicts poor prognosis and promotes cell proliferation, migration, and invasion in osteosarcoma.
Chen S; Li W; Guo A
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30944201
[TBL] [Abstract][Full Text] [Related]
14. LncSNHG16 promotes proliferation and migration of osteosarcoma cells by targeting microRNA-146a-5p.
Zheng SN; Ge DW; Tang J; Yang J; Yan JW; Qiu JJ; Yin ZW; Ni Y; Zhao L; Chen X; Yang L
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):96-104. PubMed ID: 30657551
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA tumor suppressor candidate 7 functions as a tumor suppressor and inhibits proliferation in osteosarcoma.
Cong M; Li J; Jing R; Li Z
Tumour Biol; 2016 Jul; 37(7):9441-50. PubMed ID: 26781978
[TBL] [Abstract][Full Text] [Related]
17. LncRNA FAL1 is a negative prognostic biomarker and exhibits pro-oncogenic function in osteosarcoma.
Wang Y; Zhao Z; Zhang S; Li Z; Li D; Yang S; Zhang H; Zeng X; Liu J
J Cell Biochem; 2018 Nov; 119(10):8481-8489. PubMed ID: 29987852
[TBL] [Abstract][Full Text] [Related]
18. Role of taurine upregulated gene 1 as a predictor of poor outcome in osteosarcoma.
Wang Q; Chen Q
J Cancer Res Ther; 2018 Jun; 14(Supplement):S405-S409. PubMed ID: 29970697
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of long non-coding RNA NNT-AS1 promotes osteosarcoma progression by inhibiting the tumor suppressive miR-320a.
Li C; Zhang S; Qiu T; Wang Y; Ricketts DM; Qi C
Cancer Biol Ther; 2019; 20(4):413-422. PubMed ID: 30489194
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of lncRNA HULC indicates a poor prognosis and promotes cell metastasis in osteosarcoma.
Sun XH; Yang LB; Geng XL; Wang R; Zhang ZC
Int J Clin Exp Pathol; 2015; 8(3):2994-3000. PubMed ID: 26045809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]